175 related articles for article (PubMed ID: 25505093)
1. diXa: a data infrastructure for chemical safety assessment.
Hendrickx DM; Aerts HJ; Caiment F; Clark D; Ebbels TM; Evelo CT; Gmuender H; Hebels DG; Herwig R; Hescheler J; Jennen DG; Jetten MJ; Kanterakis S; Keun HC; Matser V; Overington JP; Pilicheva E; Sarkans U; Segura-Lepe MP; Sotiriadou I; Wittenberger T; Wittwehr C; Zanzi A; Kleinjans JC
Bioinformatics; 2015 May; 31(9):1505-7. PubMed ID: 25505093
[TBL] [Abstract][Full Text] [Related]
2. Searching Online Chemical Data Repositories via the ChemAgora Portal.
Zanzi A; Wittwehr C
J Chem Inf Model; 2017 Dec; 57(12):2905-2910. PubMed ID: 29189001
[TBL] [Abstract][Full Text] [Related]
3. Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application.
Xirasagar S; Gustafson SF; Huang CC; Pan Q; Fostel J; Boyer P; Merrick BA; Tomer KB; Chan DD; Yost KJ; Choi D; Xiao N; Stasiewicz S; Bushel P; Waters MD
Bioinformatics; 2006 Apr; 22(7):874-82. PubMed ID: 16410321
[TBL] [Abstract][Full Text] [Related]
4. ArrayTrack: An FDA and Public Genomic Tool.
Fang H; Harris SC; Su Z; Chen M; Qian F; Shi L; Perkins R; Tong W
Methods Mol Biol; 2017; 1613():333-353. PubMed ID: 28849567
[TBL] [Abstract][Full Text] [Related]
5. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
6. Toxicogenomics.
Gomase VS; Tagore S
Curr Drug Metab; 2008 Mar; 9(3):250-4. PubMed ID: 18336230
[TBL] [Abstract][Full Text] [Related]
7. Progress and promises in toxicogenomics in aquatic toxicology: is technical innovation driving scientific innovation?
Fent K; Sumpter JP
Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):25-39. PubMed ID: 22099342
[TBL] [Abstract][Full Text] [Related]
8. CEBS--Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data.
Waters M; Stasiewicz S; Merrick BA; Tomer K; Bushel P; Paules R; Stegman N; Nehls G; Yost KJ; Johnson CH; Gustafson SF; Xirasagar S; Xiao N; Huang CC; Boyer P; Chan DD; Pan Q; Gong H; Taylor J; Choi D; Rashid A; Ahmed A; Howle R; Selkirk J; Tennant R; Fostel J
Nucleic Acids Res; 2008 Jan; 36(Database issue):D892-900. PubMed ID: 17962311
[TBL] [Abstract][Full Text] [Related]
9. Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures.
Grafström RC; Nymark P; Hongisto V; Spjuth O; Ceder R; Willighagen E; Hardy B; Kaski S; Kohonen P
Altern Lab Anim; 2015 Nov; 43(5):325-32. PubMed ID: 26551289
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomics in drug development.
Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
[TBL] [Abstract][Full Text] [Related]
11. Pathway analysis tools and toxicogenomics reference databases for risk assessment.
Ganter B; Zidek N; Hewitt PR; Müller D; Vladimirova A
Pharmacogenomics; 2008 Jan; 9(1):35-54. PubMed ID: 18154447
[TBL] [Abstract][Full Text] [Related]
12. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
13. Drivers of and Obstacles to the Adoption of Toxicogenomics for Chemical Risk Assessment: Insights from Social Science Perspectives.
Pain G; Hickey G; Mondou M; Crump D; Hecker M; Basu N; Maguire S
Environ Health Perspect; 2020 Oct; 128(10):105002. PubMed ID: 33112659
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the Use of Toxicogenomics to Assess Environmental Risk.
Portugal J; Mansilla S; Piña B
Front Biosci (Landmark Ed); 2022 Oct; 27(10):294. PubMed ID: 36336867
[TBL] [Abstract][Full Text] [Related]
15. Emerging Bioinformatics Methods and Resources in Drug Toxicology.
Audouze K; Taboureau O
Methods Mol Biol; 2022; 2425():133-146. PubMed ID: 35188631
[TBL] [Abstract][Full Text] [Related]
16. Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data.
Alexander-Dann B; Pruteanu LL; Oerton E; Sharma N; Berindan-Neagoe I; Módos D; Bender A
Mol Omics; 2018 Aug; 14(4):218-236. PubMed ID: 29917034
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
Ganter B; Snyder RD; Halbert DN; Lee MD
Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
[TBL] [Abstract][Full Text] [Related]
18. The Comparative Toxicogenomics Database: update 2013.
Davis AP; Murphy CG; Johnson R; Lay JM; Lennon-Hopkins K; Saraceni-Richards C; Sciaky D; King BL; Rosenstein MC; Wiegers TC; Mattingly CJ
Nucleic Acids Res; 2013 Jan; 41(Database issue):D1104-14. PubMed ID: 23093600
[TBL] [Abstract][Full Text] [Related]
19. [Toxicogenomics as a tool for evaluation of chemical effects].
Watanabe H
Yakugaku Zasshi; 2007 Dec; 127(12):1967-74. PubMed ID: 18057786
[TBL] [Abstract][Full Text] [Related]
20. A Systems Biology Approach for Identifying Hepatotoxicant Groups Based on Similarity in Mechanisms of Action and Chemical Structure.
Hebels DG; Rasche A; Herwig R; van Westen GJ; Jennen DG; Kleinjans JC
Methods Mol Biol; 2016; 1425():339-59. PubMed ID: 27311473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
